Peripheral Neuropathic Pain

Neurology
1
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

AlzeCure Pharma
AlzeCure PharmaSweden - Huddinge
1 program
1
ACD440 Gel 14mg/gPhase 21 trial
Active Trials
NCT05416931CompletedEst. Mar 2023
Astellas
AstellasChina - Shenyang
1 program
Qutenza exposureN/A1 trial
Active Trials
NCT01737294Completed429Est. Aug 2014
BlueWind Medical
BlueWind MedicalIsrael - Herzliya
1 program
The Reprieve systemN/A1 trial
Active Trials
NCT02209896CompletedEst. Mar 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AlzeCure PharmaACD440 Gel 14mg/g
BlueWind MedicalThe Reprieve system
AstellasQutenza exposure

Clinical Trials (3)

Total enrollment: 429 patients across 3 trials

NCT05416931AlzeCure PharmaACD440 Gel 14mg/g

ACD440 Gel in Peripheral Neuropathic Pain

Start: Jun 2022Est. completion: Mar 2023
Phase 2Completed
NCT02209896BlueWind MedicalThe Reprieve system

BlueWind Reprieve System for the Treatment of PNP

Start: Dec 2014Est. completion: Mar 2017
N/ACompleted
NCT01737294AstellasQutenza exposure

Observation of the Use of QUTENZA™ in Standard Clinical Practice

Start: Feb 2012Est. completion: Aug 2014429 patients
N/ACompleted

Related Jobs in Neurology

Director, Distribution & Services

Xenon Pharmaceuticals
Remote
8h ago

Senior Medical Science Liaison (NYC Tri-State)

Xenon Pharmaceuticals
Remote
8h ago
$208K - $234K/yr

Director of Medical Affairs

CoMind
Miami, FL
9h ago

Director of Finance

CoMind
London, UK
9h ago

Electronics Engineering Manager

CoMind
London, UK
9h ago

Director of Information Technology

Zavation Medical Products
9h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

Related Indications

Multiple Sclerosis(274)Schizophrenia(255)Epilepsy(242)Parkinson Disease(171)Alzheimer's Disease(165)Parkinson's Disease(160)Alzheimer Disease(117)Stroke(102)Relapsing-Remitting Multiple Sclerosis(83)Depression(82)